{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-092011","form_type":"8-K","ticker":"ITRMF","cik":"0001659323","company_name":"Iterum Therapeutics plc","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.006143+00:00","generated_at":"2026-05-31T12:19:46.126866+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Iterum Therapeutics rights offering expires; expects $7.4M gross proceeds","bullets":["Rights offering expired Aug 6, 2024; gross proceeds est. $7.4M, net ~$6.3M after $1.1M expenses.","17,007,601 rights distributed; each allowed purchase of 0.50 Units at $0.605.","Basic subscription: 6,121,965 Units; over-subscription of 5,091,550 Units fully honored.","Each Unit includes 1 share, 0.50 1-yr warrant ($1.21 strike), and 1 5-yr warrant ($1.21).","Shares and warrants expected to be delivered on or about Aug 9, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-092011","json":"https://secwatch.observer/filing/0000950170-24-092011.json","markdown":"https://secwatch.observer/filing/0000950170-24-092011.md","text":"https://secwatch.observer/filing/0000950170-24-092011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1659323/000095017024092011/0000950170-24-092011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1659323/000095017024092011/itrm-20240806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:19:46.126866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}